| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |